Reckitt Benckiser Group (OTCMKTS:RBGLY) Share Price Passes Below 200 Day Moving Average of $13.16

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $13.16 and traded as low as $11.22. Reckitt Benckiser Group shares last traded at $11.33, with a volume of 700,935 shares trading hands.

Wall Street Analyst Weigh In

Separately, BNP Paribas upgraded shares of Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research note on Tuesday, January 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, Reckitt Benckiser Group presently has an average rating of “Hold” and a consensus price target of $6,996.67.

Reckitt Benckiser Group Stock Up 0.6 %

The company’s 50 day moving average price is $11.66 and its two-hundred day moving average price is $13.16.

Reckitt Benckiser Group Increases Dividend

The company also recently disclosed a dividend, which will be paid on Monday, June 3rd. Stockholders of record on Friday, April 12th will be paid a $0.2701 dividend. The ex-dividend date is Thursday, April 11th. This is a boost from Reckitt Benckiser Group’s previous dividend of $0.18.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.